Kent Walker has more than 25 years of experience in pharmaceutical and biotechnology related industries as a pharmacist, researcher, and attorney. His extensive experience as in-house counsel at major pharmaceutical companies gives him the ability to blend a technical and legal focus with an eye to achieving optimal commercial outcomes in his counseling. He is known for his ability to analyze issues thoroughly and guiding clients to a strategy that will set them up for success.
Kent focuses his practice on helping pharmaceutical and biotechnology companies develop products and bring them to market through counseling and litigation. Prior to joining Crowell & Moring, Kent spent over 15 years as senior counsel at Actavis, Plc and Vice President of Global IP Strategy at Mylan, where he developed and managed litigation of hundreds of pharmaceutical and biosimilar products and was responsible for implementing strategies that are widely used throughout the industry today.
In addition to his primary focus, Kent has represented clients, including software companies and famous athletes, on a broad array of matters including licensing, brand protection, and commercial disputes.
Affiliations
Admitted to practice: Maryland, Utah, U.S. Patent and Trademark Office (USPTO), Supreme Court of the United States, Utah Supreme Court, U.S. District Court for the District of Utah, Maryland Court of Appeals